Proteinase-Activated Receptor 1 (PAR1) regulates leukemic stem cell functions

Area of Science:

• Hematology
• Stem Cell Biology
• Oncology

Background:

• External signals regulate stem cell fate via specific receptors.
• The thrombin receptor PAR1 is involved in various biological processes, including tumor biology.
• PAR1's role in hematopoietic stem cells and leukemia is largely unexplored.

Purpose of the Study:

• To investigate the expression and function of PAR1 in hematopoietic stem cells and acute myeloid leukemia (AML).
• To determine PAR1's impact on leukemogenesis and leukemic stem cell maintenance.

Main Methods:

• Analysis of PAR1 mRNA and protein levels in primary hematopoietic cells and AML blast cells.
• Assessment of hematopoietic stem cell engraftment and potential in constitutively Par1-deficient mice.
• Modeling AML by introducing the MLL-AF9 oncogene into wild-type and Par1-/- hematopoietic progenitor cells.
• In vitro and in vivo evaluation of leukemic stem cell function and leukemogenesis in the absence or presence of PAR1.

Main Results:

• AML blast cells exhibited significantly lower PAR1 expression compared to CD34+ progenitor cells.
• Constitutive Par1-deficiency did not impair hematopoietic stem cell engraftment or potential in mice.
• Par1-deficiency did not affect initial leukemia development but enhanced leukemic stem cell function in vitro and in vivo.
• Re-expression of PAR1 in Par1-/- leukemic stem cells delayed leukemogenesis.

Conclusions:

• PAR1 is expressed at lower levels in AML cells compared to normal hematopoietic progenitors.
• PAR1 plays a crucial role in maintaining leukemic stem cell function and promoting leukemogenesis.
• Targeting PAR1 may represent a therapeutic strategy for AML.